The profit motive and spine surgery

Spine

Volumn 29, Issue 22, 2004, Pages 2588-2591

  Weiner, Bradley K ^a   Levi, Benjamin H ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Industry; Market medicine; Profit motive; Spine surgery

Indexed keywords

ALTRUISM; EDUCATION; MARKETING; MEDICAL CARE; MOTIVATION; PATIENT CARE; PRIORITY JOURNAL; PROFIT; RESEARCH; REVIEW; SPINE DISEASE; SPINE SURGERY; SURGICAL APPROACH; SURGICAL TECHNIQUE; WOUND HEALING;

BIOMEDICAL RESEARCH; HUMANS; MARKETING OF HEALTH SERVICES; MOTIVATION; ORTHOPEDIC PROCEDURES; SPINAL DISEASES;

EID: 14844356151     PISSN: 03622436     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.brs.0000145505.84077.13     Document Type: Review

References (24)

1. Titmuss R. The Gift Relationship. New York: Vintage Books; 1971.
2. Ad Hoc Committee to Defend Health Care. For patients, not for profits. JAMA 1997;278:1733.
3. Melander H, Ahlqvist-Rastad J, Meijer G, et al. Evidence b(i)ased medicine-selective reporting from studies sponsored by pharmaceutical industry, review of studies in new drug applications. BMJ 2003;326:1171-3.
4. Lexchin J, Bero LA, Djulbegovic B, et al. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003;326: 1174-83.
5. Ubel PA, Asch DA, Jepson C. Misperceptions about beta blockers and diuretics. J Gen Intern Med 2003;18:893-902.
6. Siegel D, Lopez J. Trends in antihypertensive drug use in the United States. JAMA 1997;279:1745-8.
7. Benner P. When health care becomes a commodity. In: Kilner, Orr, Shelly, eds. The Changing Face of Health Care. Grand Rapids: Erdsmans Publishing Co; 1998.
8. Deleted in proof.
9. Cherry MJ. The market and health care reform. J Med Philos 2003;3: 259-80.
10. Pappachan JV, et al. Comparison of APACHE III outcome from intensive care admission after adjustment for case mix by the APACHE III prognostic system. Chest 1999;115:802-10.
11. Wood K, Coursin DB, Ground RM. Critical care outcomes in the united kingdom: sobering wake up call or stability of the lamppost? Chest 1999; 115:614-6.
12. Deleted in proof.
13. Lo B, Wolf LE, Berkeley A. Conflict-of-interest policies for investigators in clinical trials. N Engl J Med 2000;343:1616-20.
14. Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Section II.D. 2. Potential Conflicts of Interest Related to Project Support. Available at: http://www.icmje.org/#conflicts.
15. DeAngelis CD, Fontanarosa PB, Flanagin A. Reporting financial conflicts of interest and relationships between investigators and research sponsors. JAMA 2001;286:89-91.
16. Pullan RD, et al. Transdermal nicotine for active ulcerative colitis. N Engl J Med 1994;330:811-5.
17. Sandborn WJ, et al. Transdermal nicotine for active ulcerative colitis. Ann Intern Med 1997;126:364-71.
18. Gray R, et al. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 1996;383:713-6.
19. Nelson HD, et al. Postmenopausal hormone replacement therapy. JAMA 2002;288:872-81.
20. Nolan RE, Schmidt WL. Products liability overview. In: Cowan D, et al., eds. Human Organ Transplantation. Ann Arbor: Health Administration Press; 1987.
21. Richter HP, Kast E, et al. The German Adcon-L study. J Neurosurg 2001; 95:179-89.
22. Ganzer D, Giese K, et al. Two results after lumbar microdiscectomy with and without Adcon-L. Arch Orthop Trauma Surg 2003;123:17-21.
23. Le AX, Rogers DE, Dawson EG, et al. Unrecognized durotomy after lumbar discectomy. Spine 2001;26:115-7.
24. Hieb LD, Stevens DL. Spontaneous postoperative CSF leaks following application of anti-adhesive barrier gel. Spine 2001;26:748-51.